Publication

Publication

Safety and immunogenicity of the Ad26/protein preF RSV vaccine in adults aged 18 to 59 years with and without at-risk comorbidities for severe respiratory syncytial virus disease: A phase 3, randomized, controlled, immunobridging trial

January 1, 2025
Publication

MDMA pharmacokinetics: A population and physiologically based pharmacokinetics model-informed analysis

November 26, 2024
Publication

A Growth Differentiation Factor 15 Receptor Agonist in Randomized Placebo-Controlled Trials in Healthy or Obese Persons 

August 24, 2024
Publication

Phase 1/2a Safety and Immunogenicity of an Adenovirus 26 Vector Respiratory Syncytial Virus (RSV) Vaccine Encoding Prefusion F in Adults 18-50 Years and RSV-Seropositive Children 12-24 Months

December 28, 2022
Publication

RSVPreF3 OA Vaccine Safety in Older Adults: 6-Month Interim Analysis

December 15, 2022
Publication

Case Report: Second-Trimester Maternal COVID-19 Infection and Tetralogy of Fallot

August 9, 2021